FDA pushes MDMA to Phase II testing, identifies drug as “breakthrough” in PTSD treatment The FDA has given MDMA the okay to advance to Phase II trials in PTSD treatment, labeling the drug as a breakthrough in the study of PTSD remedy.
New research supports MDMA use to treat PTSD New research reveals MDMA-aided psychotherapy is able to ease symptoms synonymous with PTSD.